1. Volume 393, Issue 10180, Pages 1505-1516 (April 2019)
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial 
Gus Gazzard, FRCOphth, Evgenia Konstantakopoulou, PhD, Prof David Garway-Heath, MD, Anurag Garg, FRCOphth, Victoria Vickerstaff, MSc, Rachael Hunter, MSc, Gareth Ambler, PhD, Catey Bunce, DSc, Richard Wormald, FRCOphth, Neil Nathwani, BSc, Keith Barton, FRCS, Prof Gary Rubin, PhD, Marta Buszewicz, MRCGP Gareth Ambler, Keith Barton, Rupert Bourne, David Broadway, Catey Bunce, Marta Buszewicz, Amanda Davis, Anurag Garg, David Garway-Heath, Gus Gazzard, Rachael Hunter, Hari Jayaram, Yuzhen Jiang, Evgenia Konstantakopoulou, Sheng Lim, Joanna Liput, Timothy Manners, Stephen Morris, Neil Nathwani, Gary Rubin, Nicholas Strouthidis, Victoria Vickerstaff, Sarah Wilson, Richard Wormald, Haogang Zhu Gus Gazzard, FRCOphth, Evgenia Konstantakopoulou, PhD, Prof David Garway-Heath, MD, Anurag Garg, FRCOphth, Victoria Vickerstaff, MSc, Rachael Hunter, MSc, Gareth Ambler, PhD, Catey Bunce, DSc, Richard Wormald, FRCOphth, Neil Nathwani, BSc, Keith Barton, FRCS, Prof Gary Rubin, PhD, Marta Buszewicz, MRCGP Gareth Ambler, Keith Barton, Rupert Bourne, David Broadway, Catey Bunce, Marta Buszewicz, Amanda Davis, Anurag Garg, David Garway-Heath, Gus Gazzard, Rachael Hunter, Hari Jayaram, Yuzhen Jiang, Evgenia Konstantakopoulou, Sheng Lim, Joanna Liput, Timothy Manners, Stephen Morris, Neil Nathwani, Gary Rubin, Nicholas Strouthidis, Victoria Vickerstaff, Sarah Wilson, Richard Wormald, Haogang Zhu 
The Lancet 
Volume 393, Issue 10180, Pages (April 2019)
DOI: /S (18)32213-X
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

2. Figure 1
Trial profile
SLT=selective laser trabeculoplasty. *Two patients were randomised twice due to computer failure: one was initially randomised to medication but was subsequently randomised to, and received, SLT. The other was initially randomised to SLT but was subsequently randomised to, and received, medication. These patients are included in the figure according to their second randomisations. In addition, four other patients who did not meet the eligibility criteria (and could not receive treatment) were randomised in error. These patients were subsequently removed from the study and are not included in the total randomised.
The Lancet  , DOI: ( /S (18)32213-X)
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

3. Figure 2
Mean EQ-5D, GUI, GSS, and GQL-15 scores at each time point, across 36 months
Time-point ‘0’ refers to pre-treatment. EQ-5D=EuroQol 5 Dimensions 5 Levels. GUI=Glaucoma Utility Index. GSS=Glaucoma Symptom Scale. GQL-15=Glaucoma Quality of Life-15. *Higher scores indicate better health-related quality of life. †Higher scores indicate worse health-related quality of life.
The Lancet  , DOI: ( /S (18)32213-X)
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions